How does epidemic injustice interact with the world of global health governance and how can the institutions of global governance be deployed to address the problem?
The Collective Blog
Waiving intellectual property rights for COVID-19 health products and technologies is essential if we are to correct global health inequities and enable more equitable access, writes Collective member Deborah Gleeson.
About this blog
A blog written by members of The Political Determinants of Health Collective, where they discuss how their work contributes to furthering knowledge and research in this area.